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Abstract
Vibrio cholerae encodes six resistance-nodulation-division (RND) efflux systems which
function in antimicrobial resistance, virulence factor production, and intestinal colonization.
Among the six RND efflux systems, VexAB exhibited broad substrate specificity and played
a predominant role in intrinsic antimicrobial resistance. The VexAB system was encoded in
an apparent three gene operon that included vexR; which encodes an uncharacterized
TetR family regulator. In this work we examined the role of vexR in vexRAB expression. We
found that VexR bound to the vexRAB promoter and vexR deletion resulted in decreased
vexRAB expression and increased susceptibility to VexAB antimicrobial substrates. Sub-
strate-dependent induction of vexRABwas dependent on vexR and episomal vexR expres-
sion provided a growth advantage in the presence of the VexAB substrate deoxycholate.
The expression of vexRAB increased, in a vexR-dependent manner, in response to the loss
of RND efflux activity. This suggested that VexAB may function to export intracellular me-
tabolites. Support for this hypothesis was provided by data showing that vexRAB was upre-
gulated in several metabolic mutants including tryptophan biosynthetic mutants that were
predicted to accumulate indole. In addition, vexRABwas found to be upregulated in re-
sponse to exogenous indole and to contribute to indole resistance. The collective results in-
dicate that vexR is required for vexRAB expression in response to VexAB substrates and
that the VexAB RND efflux system modulates the intracellular levels of metabolites that
could otherwise accumulate to toxic levels.
Introduction
Vibrio cholerae is a noninvasive gram negative bacterial pathogen that causes the disease chol-
era. Cholera is a severe acute diarrheal disease that affects an estimated 3–5 million people per
year [1]. Untreated cholera can rapidly lead to dehydration, hypotensive shock, and death.
Cholera is contracted by ingesting V. cholerae contaminated food or water [2]. Following inges-
tion, V. cholerae colonizes the small intestine via a process that is dependent upon the
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induction of genes which are required for intestinal colonization and disease development.
These in vivo expressed genes contribute to V. cholerae pathogenesis in diverse ways and range
from traditional virulence factors (e.g. cholera toxin and the toxin co-regulated pilus) to genes
that facilitate V. cholerae survival in the gastrointestinal (GI) tract [3]. Persistence in the intes-
tine is dependent upon V. cholerae’s ability to overcome antibacterial barriers intrinsic to the
GI tract, including the presence of high concentrations of toxic small molecules (such as bile
acids and other detergent-like molecules), antimicrobial products generated by resident flora,
and products of the innate immune system. In response to these toxic compounds, V. cholerae
activates genes which function to protect the cell by modulating its outer membrane (OM) per-
meability barrier and by activating efflux transporters [4–6]. For example, in response to bile
acids V. cholerae alters the porin composition of the OM to effectively reduce the rate of bile
salt diffusion, and presumably the diffusion of other soluble toxic molecules, across the OM
[7–10]. In conjunction with reduced OM permeability, V. cholerae expresses RND-family
transport systems that function to efflux bile salts, and multiple other antimicrobial com-
pounds, from within the cell envelope to the external environment [4–6,11]. Together, the acti-
vated RND efflux systems and reduced OM permeability function synergistically to provide V.
cholerae with high-level resistance to lethal antimicrobial compounds present in the host. The
importance of these responses in the pathobiology of this organism is highlighted by the fact
that V. cholerae exhibits a greatly diminished ability to colonize the intestinal tract in the ab-
sence of these adaptive responses [5,11,12].
The RND efflux systems have been a focal point in bacterial antimicrobial resistance re-
search due to the ability of individual RND systems to provide resistance to a broad range of
chemically unrelated substrates that include antibiotics, detergents, dyes, and antimicrobial
peptides [13]. The RND efflux systems are found in most gram negative bacteria and function
as proton-substrate antiporters [14]. Individual RND efflux systems are composed of three
components: an outer membrane pore protein that is homologous to Escherichia coli TolC, an
integral cytoplasmic membrane pump protein belonging to the RND superfamily, and a peri-
plasmic membrane fusion protein that links the outer membrane pore protein to the RND
pump protein [15–18]. Together these three components form a transport apparatus that
spans the cell envelope and functions to efflux substrates from within the cell envelope into the
external environment. Although the RND transport apparatus is responsible for the efflux of
antimicrobials, phylogenetic analysis suggests that the RND efflux systems evolved indepen-
dent of xenobiotic selection [19,20]. Indeed, there is mounting evidence that the RND efflux
systems are involved in diverse functions (reviewed in [21]) such as biofilm formation, iron ac-
quisition, plant-bacteria interactions, lipid transport, bacterial virulence, divalent cation resis-
tance, and the removal of metabolic byproducts from within the cell.
The V. cholerae genome encodes six RND efflux systems [22]. Inhibition of the RND efflux
systems renders V. cholerae hypersensitive to multiple antimicrobial compounds and attenuates
the expression of virulence factors including cholera toxin (CT) and the toxin co-regulated pilus
(TCP) [4,23,24]. Among the six RND efflux systems, the VexAB system was shown to be the pri-
mary system that contributes to intrinsic antimicrobial resistance in vitro [4,5]. Several studies
have suggested that the V. cholerae VexAB RND efflux system is important to V. cholerae patho-
genesis. This included finding that vexAB was induced in vivo in humans and animals [25], that
vexAB expression was enhanced by the Cpx system [26], and that VexAB was required for high-
level virulence factor production [5]. While there is ample evidence to suggest that VexAB is im-
portant in pathogenesis, the regulatory mechanisms controlling its expression are unknown.
In many bacteria regulation of the RND efflux systems is mediated by a linked TetR family
regulator [27]. The TetR family of regulatory proteins function in diverse phenotypes including
antibiotic resistance, metabolism, stress responses, and pathogenicity [28]. TetR proteins
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contain two functional domains: a conserved N-terminal DNA-binding domain and a variant
C-terminal ligand binding domain [28]. The ligand binding domain is capable of binding to ef-
fector molecules that modulate the interaction of the DNA binding domain with its target se-
quences. In the case of RND efflux systems, the activity of the RND efflux system’s TetR
regulators is often modulated by the binding of efflux substrates of the linked RND system. In
many cases, TetR proteins appear to be capable of binding a diverse set of ligands that corre-
spond to the multiple substrates of linked RND efflux systems [28]. The vast majority of re-
ported TetR family regulators function as repressors that bind the promoter region and repress
transcription in the absence of bound ligands [29,30]. In addition to regulating their specific
target genes, many TetR regulators also regulate their own expression [27,28].
In this work we tested the hypothesis that the TetR family protein VexR regulated the ex-
pression of the vexAB RND efflux system [22,31,32]. VexR, which has not been characterized,
was encoded by the first gene in a three gene operon that included vexA and vexB; a genetic or-
ganization that was distinct from most RND efflux systems [28,29]. Our results confirmed that
VexR functioned in the regulation of the vexRAB operon, but in a manner that was opposite to
most RND efflux system associated TetR regulators. Our results indicated that VexR was re-
quired for activation of the vexRAB operon, whereas most RND-linked TetR regulators func-
tion as repressors. We further found that the vexRAB promoter was upregulated, in a vexR-
dependent manner, in response to the loss of RND efflux activity. This suggested that endoge-
nous metabolites may serve as activators of the vexRAB efflux operon and could be VexAB sub-
strates. Consistent with this idea, vexRAB was upregulated in several metabolic mutants,
including tryptophan biosynthetic mutants. Furthermore indole, an intermediate in trypto-
phan biosynthesis, induced vexRAB expression. Taken together our results suggested that
VexR was required for activation of the vexRAB operon. We further posit that a native role of
the VexAB RND efflux system is to remove excess cellular metabolites from within the cell that
could otherwise accumulate to toxic levels.
Materials and Methods
Bacterial strains and culture conditions
The bacterial strains used in this study are listed in Table 1. Escherichia coli EC100Dpir+,
SM10λpir, and ER2566 were used for cloning, plasmid mobilization, and protein purification, re-
spectively. Vibrio cholerae strains used in this study were derivatives of O1 El Tor strains N16961
and C6706 [22,33,34]. V. cholerae strain JB58 (N16961-ΔlacZ SmR) or JB804 (C6706-lacZ+ SmR)
were used as wild-type (WT) control strains as indicated. The C6706 transposon mutants [33]
were graciously supplied by Dr. JohnMekalanos (Harvard Medical School). Bacterial strains were
grown at 37°C in Luria-Bertani (LB) broth or on LB agar. AKI broth was used for virulence induc-
ing conditions as described previously [5]. Bacterial stocks were maintained at -80°C in LB broth
containing 25% glycerol. Growth media was supplemented with carbenicillin (Cb) and strepto-
mycin (Sm) at 100 μg/mL, kanamycin (Km) at 50 μg/mL, or chloramphenicol (Cm) at 1μg/mL
(for V. cholerae) and 20 μg/mL (for E. coli) as required. Bacterial growth media was purchased
from Difco (Lawrence, KS) and chemicals were purchased from Sigma-Aldrich (St Louis, MO).
Growth curves were generated as follows. The indicated strains were grown overnight in LB
broth and normalized to an OD600 of 1.0. The cultures were then diluted 1:20,000 into LB
broth with or without arabinose and/or deoxycholate as indicated. Aliquots of 100μL of each
strain were then distributed in triplicate into the wells of a flat bottom 96-well microtiter plate.
The 96-well plate was then incubated in a BioTek ELx808 plate reader at 37°C with intermittent
shaking and growth was monitored by measuring the absorbance at 600 nm every 20 min for
14h. The data was then averaged for the triplicate samples at each time point.
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Table 1. Strains, plasmids and oligonucleotides.
Strain: Genotype: Source:
Vibrio cholerae
JB804 01 El Tor strain C6706, Smr [34]
JB3 01 El Tor strain N16961, Smr [4]
JB58 01 El Tor strain N16961 ΔlacZ, Smr [4]
JB114 JB58 ΔvexM [5]
JB116 JB58 ΔvexH [5]
JB432 JB58 ΔvexF [5]
JB464 JB58 ΔvexD ΔvexF ΔvexH ΔvexK ΔvexM [5]
JB485 JB58 ΔvexB ΔvexD ΔvexF ΔvexH ΔvexK ΔvexM [5]
JB495 JB58 ΔvexB [4]
JB528 JB58 ΔvexK [5]
JB692 JB58 ΔvexD [4]
JB694 JB58 ΔvexB ΔvexD [4]
JB718 JB58 ΔvexR ΔvexD This study
XBV218 JB58 ΔvexR This study
XBV220 JB58 ΔvexR ΔvexB ΔvexD ΔvexF ΔvexH ΔvexK ΔvexM This study
MKW589 ΔcpxR lacZ::cpxP-lacZ [26]
DT1458 JB58 lacZ::cpxP-lacZ [26]
DT1572 JB58ΔvexB lacZ::cpxP-lacZ [26]
DT1460 JB485 lacZ::cpxP-lacZ [26]
DT1693 JB495 lacZ::cpxP-lacZ This study
VA367 JB58 ΔvexR ΔcpxR lacZ::cpxP-lacZ This study
EC8508 C6706 Tn::VC0027(ilvA) [33]
EC20412 C6706 Tn::VC0051(purK) [33]
EC1769 C6706 Tn::VC0052(purE) [33]
EC23411 C6706 Tn::VC0164(vexB) [33]
EC24273 C6706 Tn::VC0374(pgi) [33]
EC14462 C6706 Tn::VC0384(cysJ) [33]
EC5082 C6706 Tn::VC0385(cysI) [33]
EC9587 C6706 Tn::VC0386(cysH) [33]
EC19978 C6706 Tn::VC0537(cysM) [33]
EC11960 C6706 Tn::VC0767(guaB) [33]
EC4709 C6706 Tn::VC0774 [33]
EC11507 C6706 Tn::VC0819(aldA-1) [33]
EC8862 C6706 Tn::VC0923 [33]
EC11848 C6706 Tn::VC0968(cysK) [33]
EC10232 C6706 Tn::VC1061 [33]
EC5818 C6706 Tn::VC1169(trpA) [33]
EC24412 C6706 Tn::VC1170(trpB) [33]
EC12331 C6706 Tn::VC1171(trpC/F) [33]
EC11883 C6706 Tn::VC1172(trpD) [33]
EC11883 C6706 Tn::VC1173(trpG) [33]
EC11131 C6706 Tn::VC1174(trpE) [33]
EC1872 C6706 Tn::VC1579 [33]
EC389 C6706 Tn::VC1732(aroA) [33]
EC14803 C6706 Tn::VC1819(aldA-2) [33]
(Continued)
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Table 1. (Continued)
Strain: Genotype: Source:
EC12803 C6706 Tn::VC2013(ptsG) [33]
EC7541 C6706 Tn::VC2092(gltA) [33]
EC18511 C6706 Tn::VC2209(vibF) [33]
EC10553 C6706 Tn::VC2348(deoB) [33]
EC24541 C6706 Tn::VC2362(thrC) [33]
EC19558 C6706 Tn::VC2363(thrB) [33]
EC13310 C6706 Tn::VC2364(thrA) [33]
EC1335 C6706 Tn::VC2558(cysC) [33]
EC13560 C6706 Tn::VC2559(cysN) [33]
EC21282 C6706 Tn::VC2560(cysD) [33]
EC9914 C6706 Tn::VC2649(cysE) [33]
EC20144 C6706 Tn::VCA0013(malP) [33]
EC2460 C6706 Tn::VCA0014(malQ) [33]
EC4499 C6706 Tn::VCA0765(ybjU) [33]
EC9834 C6706 Tn::VCA0886(kbl) [33]
EC3123 C6706 Tn::VCA0896(zwf) [33]
EC14445 C6706 Tn::VCA0987(ppsA) [33]
EC21873 C6706 Tn::VCA1046(mtlD) [33]
Escherichia coli
EC100Dpir+ F- mcrA Δ(mrr-hsdRMS-mcrBC) Φ80dlacZΔM15 ΔlacX74 recA1 endA1 araD139 Δ(ara, leu)7697 galU galK λ-
rpsL (SmR) nupG pir+
Epicentre
SM10λpir thi-1 thr leu tonA lacY supE recA::RP4-2-4-Tc::Mu KmR (λ pirR6K) [62]
ER2566 F- glnV44(AS) galK2(Oc) rpsL704(strR) xylA5 mtl-1 argE3(Oc) thiE1 tfr-3 λ DE3 = λ sBamHIo ΔEcoRI-B int::
(lacI::PlacUV5::T7 gene1) i21 Δnin5
New England
BioLabs
Plasmids: Description:
pBAD18 Expression plasmid, CbR, pBR322 origin of replication [63]
pCM10 Vector for construction of luxCDABE transcriptional fusions, KmR, ori101 [64]
pDT1076 pCM10 containing the vexR promoter region from N16961 This study
pDT1146 pMMB66EH::vexR This study
pDT1777 pDT1076 with Cm-mark cassette inserted into the vector, CmR This study
pJB703 pBAD18::vexR This study
pMAL-c2 Expression plasmid for fusion of proteins to MBP and cytoplasmic expression, CbR, pBR322 origin of
replication
New England
BioLabs
pMMB66EH Expression plasmid, CbR, oriV/T [7]
pSC137 Vector for transposon mutagenesis of bacteria, CmR, oriR6K
pMAL-c2::vexR vexR cloned into pMAL-c2 This study
pTL61T Vector for construction of lacZ transcriptional fusions, CbR, oriRK2 [12]
pWM91 Suicide plasmid vector used for allelic exchange, CbR, oriR6K/fl [65]
pWM91::ΔvexR pWM91::ΔvexR This study
pXB233 pTL61T containing the vexR promoter region from N16961 This study
pXB228 pTL61T containing the vexEF promoter region [26]
pXB229 pTL61T containing the vexGH promoter region [26]
pXB230 pTL61T containing the vexIJK promoter region [26]
pXB231 pTL61T containing the vexCD promoter region [26]
pXB232 pTL61T containing the vexLM promoter region [26]
pΔR cpxR::Km allelic exchange vector [37]
pJL1P’Z Allelic exchange vector for placing cpxP-lacZ into the V. cholerae genome [37]
(Continued)
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Plasmid and mutant construction
Plasmids and oligonucleotides used in this study are listed in Table 1. Enzymes for cloning ex-
periments were purchased from New England Biolabs (Beverly, MA). pXB233 (PvexRAB-lacZ)
was constructed as follows. The 166c-F-XhoI and 166c-R-XbaI PCR primers were used to am-
plify the vexRAB promoter from N16961 genomic DNA. The resulting PCR amplicon was
then restricted with XhoI and XbaI endonucleases before being ligated into the XhoI/XbaI site
of pTL61T to generate pXB233 (PvexRAB-lacZ). pDT1076 (PvexRAB-lux) was generated by cloning
the vexRAB promoter from pXB233 into pCM10 as follows. The vexRAB promoter was PCR
amplified from pXB233 using the XWL-BRL-F and166c-F-XhoI PCR primers. The resulting
PCR amplicon was then made blunt-ended before being restricted with BamHI. The resulting
fragment was then cloned into pCM10 linearized with EcoRI, and then blunt-ended, before
being restricted with BamHI. A Cm-marked version of pDT1076 was generated by transposing
the Cm-marked mariner transposon from pSC137 into pDT1076 to yield pDT1777. All plas-
mids were verified by DNA sequencing.
The vexR expression plasmids were constructed as follows. pJB703 was generated by ampli-
fying vexR from N16961 using the VC0166F-SacI and VC0166-XbaI-R PCR primers. The re-
sulting amplicon was restricted with SacI and XbaI endonucleases before being ligated with
similarly digested pBAD18. pDT1146 (pMMB66EH::vexR) was generated by amplifying the
vexR gene from N16961 using the VC0166F-SacI and MCS4.VexA.R primers. The resulting
amplicon was blunt-ended, digested with BamHI, and then ligated with similarly treated
pMMB66EH to generate pDT1146. The sequence of vexR in both plasmids was confirmed by
DNA sequencing. pMAL-c2-vexR was constructed by amplifying the vexR gene from N16961
Table 1. (Continued)
Strain: Genotype: Source:
Oligonucleotides: DNA sequence (5’–3’)::
166b-F-XhoI AACTCGAGGCAGAGAAATGTGATGT
166b-R-XbaI AATCTAGAGCCAAACAGCAGGATCG
166c-F-XhoI TTCTCGAGGGGTCCGGAGACGTACT
166c-R-XbaI CGTCTAGAGGAGCTGTTTATCGCCG
Biotin GCGGGAGTCGGCAGCG
MCS4.VexA.R CCGGATCCCATTCTGGTGCGAACTCCAAATTAGTGTTG
VC0166-SacI-F CTGAGCTCAAGGGTTCATATGCA
VC0166-XbaI-R TTTCTAGATTAGTGTTGAGTAATTGCA
VC0166-F1 CAGGATCCACTTTAGCACCGTTACTCAG
VC0166-F2 TCATTGCATCCTGTTTATCGCCGTACACTATTTC
VC0166-R1 ACCTCGAGTATTGGCCAGTATGACCTTG
VC0166-R2 CGATAAACAGGATGCAATGATTCAAGCCAGTTGG
VC0166-F-pMAL-
SmaI
GGCCCGGGTTGCAGAGAAATGTGATGTCTGAAATAGTG
VC0166-R-pMal-
EcoR1
GGAATTCTTAGTGTTGAGTAATTGCATCC
vexR-F1 GCGGGAGTCGGCAGCGATAATAATCCGCTCACCGAG
vexR-R1 GCGGGAGTCGGCAGCGCCCCTGTTTTGCAATACACTTG
vexR-F2 GCGGGAGTCGGCAGCGTGCAAAACAGGGGGTATTAG
vexR-R2 GCGGGAGTCGGCAGCGGCCGTACACTATTTCAGACA
XWL-BRL-F CGCAGGGTTTTCCCAGTCACGAC
doi:10.1371/journal.pone.0117890.t001
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using the VC0166-F-pMAL-SmaI and VC0166-R-pMal-EcoRI PCR primers. The resulting
PCR amplicon was then digested with EcoRI and SmaI endonucleases and cloned into the
same sites of pMAL-c2 (New England Biolabs).
The allelic exchange vector pWM91::ΔvexR was generated by crossover PCR as previously
described [4,5,35,36]. Briefly, vexR-specific VC0166-F1/-R2 and VC0166-F2/-R1 PCR primer
pairs (Table 1) were used in separate PCR reactions with N16961 genomic DNA as a template.
The resulting ~1.1 Kb PCR products were gel purified, pooled, and then used as the template for
a second PCR reaction using the flanking VC0166-F1/-R1 PCR primers to generate the ~2.2 Kb
vexR deletion construct. The resulting ~2.2 Kb PCR amplicon was then purified, restricted with
XhoI and BamHI endonucleases before being ligated with similarly digested pWM91 to generate
pWM91::ΔvexR. The resulting plasmid was then used to delete vexR. Briefly, pWM91::ΔvexR was
conjugated into the V. cholerae and cointegrants were selected for Cb/Sm resistance. Several Cb/
Sm resistant colonies were then streaked for single colonies onto LB agar (without NaCl) contain-
ing 5% sucrose to select for loss of the integrated plasmid. Several sucrose-resistant colonies were
screened for Cb sensitivity to verify plasmid loss before the vexR deletion was confirmed by PCR
using flanking primers.
Deletion of cpxR was accomplished by allelic exchange using pΔR as previously described
[26,37]. The cpxP-lacZ chromosomal reporter was introduced into the lacZ locus using
pJL1P’Z as previously described [26,37].
Reporter assays
The β-galactosidase assays were performed as follows. Test strains were grown in LB broth or
under AKI conditions and culture aliquots were taken in triplicate at the indicated time points
post-inoculation to quantify β-galactosidase activity as previously described [7]. All experi-
ments were performed at least three times and the results averaged. Statistical significance was
determined using ANOVA with indicated post-test.
The bioluminescence reporter assays were performed as follows. E. coli EC100Dpir+ con-
taining pDT1041 and pDT1124 (or pBAD18) were grown overnight in LB broth before being
diluted 1:200 into fresh LB broth with or without 0.2% arabinose. Aliquots (100μL) of the dilut-
ed cultures were then distributed in triplicate into the wells of white 96-well microtiter plates
with clear bottoms (Corning) and incubated with shaking at 37°C for the duration of the assay.
Luminescence and the OD600 at indicated time points were determined using a BioTek Synergy
HT plate reader. The reported results are the average relative light units (RLU) for each test
sample divided by the optical density.
Quantification of vexRAB expression in the C6706 transposon mutants was accomplished
using pDT1777 (vexRAB-lux) as follows. Strains grown in LB broth were diluted 1:200 from the
overnight culture into fresh LB broth with Cm and grown under the same conditions as listed
above. Strains grown under AKI conditions were diluted 1:10,000 into AKI broth with Cm. Ali-
quots (370μL) of the diluted cultures were then distributed in triplicate as described above.
Plates were incubated statically at 37°C for 4h, at which point 215μL of culture was removed
from each well for a final volume of 155μL/well. Plates were then grown with shaking at 37°C
for the remainder of the assay. Luminescence production was determined as described above.
The results are the average RLUs for each test sample divided by the optical density. Two-way
ANOVA with Dunnet’s post-hoc test was used to determine significance relative toWT.
Antimicrobial susceptibility assays
Antimicrobial susceptibility tests were performed using gradient agar plates as previously de-
scribed [5]. Each 9 cm x 9 cm gradient plate was inoculated with six V. cholerae strains,
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including WT which served as an internal control. The plates were then incubated overnight at
37°C before growth was measured. The minimum inhibitory concentration (MIC) of each
strain was calculated by the percent growth across the plate multiplied by the antimicrobial
concentration used in the plate. One-Way ANOVA with Tukey’s multiple comparison post-
test or with Dunnet’s post-hoc test, as indicated, was used to calculate the level of significance
for the tested strains.
Purification of VexR
Proteins for the gel mobility shift assay were purified as follows. E. coli ER2566 carrying
pMAL-c2 or pMAL-c2-vexR were grown overnight at 37°C with aeration. The cultures were
then diluted 100-fold into LB broth with Cb and incubated at 37°C with shaking until reaching
an OD600 of ~0.5 when isopropyl β-D-1-thiogalactopyranoside (IPTG) was added to a final
concentration of 0.3 mM and the cultures were incubated for an additional 2 h. The cells were
then harvested by centrifugation, the supernatant removed, and the pellet resuspended in col-
umn buffer (20 mM Tris-HCl, 200 mMNaCl, 1 mM EDTA) plus 1 mM phenylmethylsulfonyl
fluoride (PMSF). The cells were then lysed using a M-11P Microfluidizer processor according
to the manufacturer’s instructions (Microfluidics). The resulting lysates were cleared of partic-
ulate matter by centrifugation at 15,000 x g for 20 min at 4°C. The clarified supernatants (i.e.
VexR-MBP or MBP) were diluted 1:6 with column buffer and loaded onto a 0.8 x 7 cm column
containing 1 mL of amylose resin (New England Biolabs). The column was washed with 12 col-
umn volumes of column buffer before the bound proteins were eluted with elution buffer (20
mM Tris-HCl, 200 mMNaCl, 1 mM EDTA, 10 mMmaltose). Protein concentrations were de-
termined using the Coomassie Plus Assay kit according to manufacturer’s instructions
(Thermo Scientific). The purity of the eluted proteins were assessed by SDS–PAGE with Coo-
massie Brilliant Blue R-250 staining.
Electrophoretic Mobility Shift Assay (EMSA)
DNA fragments designated vexR1 (the nucleotide sequence between -129 and -46 of the vexR
promoter region) and vexR2 (-59 to +21 of the vexR promoter region) were amplified from
N16961 using the primers vexR-F1/vexR-R1 and vexR-F2/vexR-R2 primers, respectively. The
fragments were then used as a template for a second PCR reaction with the flanking biotin
primer. The biotin primer was biotinylated by the manufacturer (IDT) to end label the frag-
ments. The resulting biotinylated probes (2.5 nM) were incubated with purified VexR-MBP or
MBP in amounts ranging from 0 to 250 nM in 10 μl of binding buffer containing 10 mM Tris
(pH 7.4), 150 mM KCl, 0.1 mM DTT, 0.1 mM EDTA (pH 8), and 200 μg/mL sheared salmon
sperm DNA. The binding reactions were incubated at room temperature for 20 min before
being subjected to electrophoresis on a nondenaturing 5% polyacrylamide TBE gel in 0.25x
TBE buffer at 200V for 45 min. The DNA in the gel was transferred to a nylon membrane in
0.5x TBE buffer at 380 mA for 1 h, UV cross-linked, before the biotinylated probes were de-
tected using the Chemiluminescent Nucleic Acid Detection Module (Thermo Scientific) and
documented using a FluorChem E imaging system (Protein Simple).
Results
Genetic organization of the vexRAB operon
In many gram negative bacteria the RND efflux systems encode a linked TetR family regulatory
protein that functions as a repressor of the linked RND efflux system [27,28]. The V. cholerae ge-
nome encodes six RND efflux systems; among these six, only the VexAB RND system contained
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a linked TetR-family regulator which was previously named vexR (VC0166) [4,22]. The vexR
gene was present as the first gene in the vexRAB operon (Fig. 1A). Relative to most other RND
efflux systems, the genetic arrangement of vexR within the vexRAB operon is unusual [27–29].
In most RND efflux systems that encode a linked TetR regulator, the regulatory gene is expressed
from a divergently expressed promoter that is upstream of and overlaps with the RND efflux sys-
tem promoter. This arrangement is demonstrated by the archetypical acrAB RND efflux system
in E. coli where acrR is encoded upstream and divergently from the acrAB efflux system (Fig. 1B)
[28]. The AcrR protein functions to regulate the expression of the acrAB RND system in re-
sponse to its antimicrobial substrates while also regulating its own expression [38].
Expression of vexRAB is induced in response to VexAB efflux substrates
The role of the RND efflux pumps is to export their substrates out of the cell. As such, their ex-
pression is typically regulated by a feedback loop in response to the presence of their efflux sub-
strates [28]. Since bile salts were shown to be major substrates of VexAB [4,5], we hypothesized
that vexRAB expression may be regulated in response to bile salts. To test this we cultured V.
cholerae JB58 (ΔlacZ) under virulence gene inducing conditions in AKI broth containing sub-
lethal concentrations of deoxycholate and measured vexRAB expression using a vexRAB-lacZ
reporter (i.e. pXB233). AKI growth conditions were selected because previous studies had indi-
cated a linkage between RND efflux and virulence gene expression [5]. We also tested erythro-
mycin, an antibiotic that is a substrate of VexAB. The results showed a concentration-
dependent induction of vexRAB expression in response to both erythromycin (Fig. 2A) and
deoxycholate (Fig. 2B). Deoxycholate at 0.2% resulted in a 2-fold increase in vexRAB expres-
sion while the presence of erythromycin at 0.2 μg/mL resulted in a nearly 3-fold increase in vex-
RAB expression. Based on these results we concluded that the vexRAB operon is regulated in
response to deoxycholate and erythromycin, two of its known efflux substrates.
VexR is required for expression of the vexRAB operon
The finding that vexRAB expression was induced in response to VexAB efflux substrates indi-
cated the possibility that the vexRAB system was regulated in a fashion that was similar to
other RND efflux systems. Given that most TetR-family regulators function as repressors in
the absence of their efflux substrates, we hypothesized that VexR would function to repress vex-
RAB expression. If this was true, then deletion of vexR should result in increased vexRAB ex-
pression. We therefore compared vexRAB-lacZ expression in JB58 and an isogenic ΔvexR
mutant strain. The strains were grown in LB broth to an OD600 of 0.8 when vexRAB-lacZ
Fig 1. Genetic organization of RND efflux systems. (A) Schematic of the V. cholerae vexRAB operon. (B)
Schematic of the E. coli acrR-acrAB locus. Genes encoding a TetR-family (white), membrane fusion family
(grey), and RND-family (black) proteins are shown. Putative promoters for each respective operon are
indicated by the thin black arrows.
doi:10.1371/journal.pone.0117890.g001
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expression was quantified. The results showed that vexRAB expression was significantly de-
creased in the ΔvexR strain relative to WT (Fig. 3A). This finding suggested that VexR was a
positive, rather than a negative regulator of the vexRAB operon.
We examined whether the substrate-dependent induction is contingent on the presence of
vexR because vexRAB expression was increased in response to the VexAB substrates (Fig. 2).
We chose to focus on deoxycholate as an inducer because it is the biologically most relevant
vexAB substrate with regards to V. cholerae pathogenesis [5]. Growth of WT in the presence of
0.2% deoxycholate resulted in a ~5.5-fold increase in vexRAB-lacZ expression (Fig. 3A). Dele-
tion of vexR greatly reduced the deoxycholate-dependent induction of vexRAB expression.
This result further supported the conclusion that vexR was required for vexRAB expression.
While VexR appeared to be required for robust vexRAB expression, deoxycholate still induced
vexRAB expression by ~2-fold in the ΔvexR strain relative to the LB broth control, although the
expression level was greatly reduced compared to JB58 grown in LB broth (Fig. 3A). This sug-
gested that there may be other factors involved in regulating vexRAB expression; a scenario
similar to the E. coli acrAB operon where multiple factors contribute to its expression. Taken
together these findings show that vexR contributes to the positive regulation of vexRAB.
The VexAB RND efflux system is the only RND efflux system that encodes a linked regula-
tory system. While the VexCD RND efflux system has been shown to be under negative control
by BreR [6], the regulatory mechanisms controlling the expression of the other five RND efflux
systems were unknown. We therefore tested the hypothesis that VexR may regulate the expres-
sion of the other five RND efflux systems. We introduced plasmid based lacZ reporters for
each of the other five RND efflux systems (i.e. vexCD, vexEF, vexGH, vexIJK, and vexLM) into
JB58 and its isogenic vexR deletion strain. The resulting strains were then cultured in LB broth
in the presence or absence of 0.02% deoxycholate for two hours when β-galactosidase activity
was quantified. The results showed that there was no significant difference in the expression of
the five tested RND efflux systems in WT relative to the ΔvexRmutant under either growth
condition (S1 Fig.). From this we concluded that vexR was specific for the vexRAB operon.
To further confirm that VexR contributes to activation of the vexRAB operon we tested
whether recombinant vexR expression would activate transcription of the vexRAB promoter in
Fig 2. VexAB efflux substrates affect vexRAB expression. V. cholerae strain JB58 (ΔlacZ SmR)
containing pXB233 (vexRAB-lacZ) was grown under AKI conditions for 5 h with the indicated concentrations
of (A) erythromycin or (B) deoxycholate when vexRAB expression was quantified as described in the
methods. The reported data are in Miller Units (MU) and are the mean ± SD of three independent
experiments. Statistical significance was determined relative to the media control by one-way ANOVA with
Dunnet’s post-hoc test. * = P<0.05.
doi:10.1371/journal.pone.0117890.g002
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E. coli. We therefore transformed E. coli bearing pDT1076 (vexRAB-lux) with pBAD18 (empty
vector control) or pBAD18::vexR. The resulting strains were then grown in LB broth plus or
minus 0.2% arabinose (to induce vexR expression from the arabinose inducible promoter in
pBAD18) and luminescence production was measured at zero, one and two hours. The results
showed that the empty vector control (i.e. pBAD18) did not affect vexRAB expression
(Fig. 3B). This indicated that neither pBAD18, nor arabinose, affected the expression of the
vexRAB-lux reporter. In contrast, there was a marked increase in luminescence production in
the strain containing pBAD18::vexR. The presence of pBAD18::vexR, even in the absence of
arabinose, was sufficient to induce vexRAB expression as evidenced by the increase in lumines-
cence production at one and two hours (Fig. 3B); this may reflect leaky vexR expression from
pBAD18::vexR. The addition of arabinose to the broth further increased vexRAB expression.
Based on these results, plus the results presented in Fig. 3A, we concluded that vexR contributes
to positive regulation of the vexRAB operon.
Fig 3. VexR is required for vexRAB expression. (A) N16961WT and ΔvexR containing pXB233 (vexRAB-
lacZ)were grown in LB broth. At 3.5h deoxycholate (DOC) was added to a final concentration of 0.2% and the
cultures were incubated for an additional 30 min before vexRAB expression was determined as described in the
methods. Data is the mean of three independent experiments ± SD. Significance was determine by one-way
ANOVA with Tukey-Kramer multiple comparison test. Unless otherwise indicated, asterisks are significance
relative toWT (*p<0.05; **p<0.001). (B) E. coli containing pDT1076(vexRAB-lux) and either pJB703
(pBAD18::vexR) or pBAD18 was grown in LB broth with or without 0.2% arabinose and bioluminescence was
assayed at 0h, 1h, and 2h. Error bars indicate the mean ± SD of three replicates. The results are representative
of three independent experiments. (C) Gel mobility shift assay showing the binding of VexR to the vexRAB
promoter. The promoter was split into two fragments (vexR1) -129 to -46 and (vexR2) -59 to +21 relative to the
ATG start site. Biotin labeled DNA (2.5nM) from vexR1 (lane 1–4) or vexR2 (lane 5–12) fragments was
incubated with either purified VexR-MBP or MBP as indicated at 0 nM (lane 1), 25 nM (lane 2), 100 nM (lane 3),
or 250 nM (lane 4) prior to electrophoresis. Specific binding reaction, detection, and visualization are discussed
in the Material and Methods.
doi:10.1371/journal.pone.0117890.g003
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VexR binds to the vexRAB promoter directly
The above experiments suggested that VexR may act directly at the vexRAB promoter. To test
this hypothesis we performed gel mobility shift assays using VexR-MBP with the vexRAB pro-
moter. The 5’ upstream region of vexRAB was arbitrarily split into two fragments that covered
from -129 to -46 (vexR1) and -59 to +21 (vexR2) relative to the ATG start site (Fig. 3C). The re-
sults of the gel shift assays showed that purified VexR-MBP was able to shift the vexR2 promot-
er fragment, but not the vexR1 promoter fragment. Incubation of the vexR2 fragment with
MBP did not result in a shift confirming that the results were due to VexR (Fig. 3C). These re-
sults validated that VexR directly binds to the vexRAB promoter and supports the conclusion
that VexR directly regulates vexRAB expression.
VexR contributes to antimicrobial resistance
If VexR contributes to positive regulation of the vexRAB operon, we hypothesized that the dele-
tion of vexR should increase V. cholerae susceptibility to antimicrobial compounds that are
substrates of VexAB. To test this we determined the MIC of deoxycholate, erythromycin, and
Triton X-100 for WT strain JB58 and its isogenic ΔvexRmutant. While deoxycholate, erythro-
mycin, and Triton X-100 are all substrates of VexAB, other RND efflux systems possess redun-
dant efflux activity for deoxycholate and Triton X-100. The results showed a 2.7-fold decrease
in the erythromycin MIC in the ΔvexRmutant (Table 2). In contrast, there was no change in
the susceptibility of the ΔvexRmutant to deoxycholate or Triton X-100. These results contrast
the resistance profile of a ΔvexBmutant. For example, the erythromycin MIC for the vexRmu-
tant was 1.65 μg/mL compared to 0.07 μg/mL for the vexBmutant. Likewise, the Triton X-100
MIC for the vexRmutant was>3% while the vexBmutant MIC was 0.0017%. This indicated
that the vexRmutant exhibited a phenotype that was intermediate between WT and the ΔvexB
strain. Since VexB is the only RND efflux pump that contributes to erythromycin resistance
[4], these results suggest that vexAB is expressed at a low basal level in the ΔvexRmutant.
The fact that vexR deletion did not affect deoxycholate resistance was expected as previous
studies have shown that the VexCD RND efflux system was redundant with VexAB for bile salt
resistance [4]. Because of overlapping specificity for deoxycholate, mutation of both vexB and
vexD are required to produce a bile salt hypersensitive phenotype [4]. Therefore, to address
whether vexR contributed to deoxycholate resistance we examined the effect of vexR deletion
Table 2. Antimicrobial susceptibility of vexR mutants.
Strain Genotype MIC (s.d.)1
Em (μg/mL) Doc (%) TX-100 (%)
JB58 WT 4.40 (2.1) >3 (0) >3 (0)
XBV218 ΔvexR 1.65 (0.9)2,3 >3 (0) >3 (0)
JB495 ΔvexB 0.07 (0.005)2 >3 (0) 0.0017 (0.0011)2
JB692 ΔvexD ND >3 (0) ND
JB718 ΔvexRΔvexD ND 0.020 (0.001)2,4 ND
JB694 ΔvexBΔvexD ND 0.007 (0.003)2 ND
(1)Minimum Inhibitory Concentration (MIC) for erythromycin (Em), deoxycholate (Doc), and Triton X-100 (TX-100) for the indicated N16961 strains with
standard deviations in parenthesis.
(2) P< 0.05 relative to WT.
(3) P<0.05 relative to ΔvexB.
(4) P<0.05 relative to ΔvexBD. ND = not determined.
doi:10.1371/journal.pone.0117890.t002
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in a ΔvexD background. The results showed that deletion of vexR in a ΔvexD background re-
duced the deoxycholate MIC to 0.019%; a MIC that was 2.7-fold greater than the deoxycholate
MIC observed with the ΔvexBΔvexDmutant (Table 2). The intermediate resistance phenotype
of the ΔvexRΔvexDmutant (relative to the ΔvexBΔvexDmutant) further supported the conclu-
sion that the vexRAB efflux system is expressed at a low basal level in the vexRmutant.
VexAB is the primary RND efflux system involved in Triton X-100 resistance [4]. Consis-
tent with this, a>1,700-fold increase in Triton X-100 susceptibility was observed in a ΔvexB
mutant (Table 2). However, deletion of vexR did not affect Triton X-100 susceptibility
(Table 2). This suggests that the low-level vexAB expression in the vexRmutant was sufficient
to provide WT-level Triton X-100 resistance. Alternatively, it is possible that deletion of vexR
resulted in the induction of other resistance traits that contributed to Triton X-100 resistance
and thus compensated for the reduction in vexRAB expression in the vexRmutant.
The collective MIC data indicated that VexR was required for maximum resistance to eryth-
romycin and deoxycholate under the tested conditions. When vexR was deleted, the contribu-
tion of VexAB to antimicrobial resistance was significantly reduced, but not to a level that was
equal to a vexB null mutant. This suggested that vexAB was expressed at a low basal level in
the ΔvexRmutant.
We recently reported that activation of the Cpx membrane stress response system can en-
hance vexRAB expression in V. cholerae [26]. We also showed that vexB deletion resulted in ac-
tivation of the V. cholerae Cpx system which suggested that vexRAB and the Cpx system were
reciprocally regulated. Based on this we hypothesize that if vexR was required for vexAB ex-
pression, then mutation of vexR should also result in activation of the Cpx system. To test this
hypothesis we assayed cpxP expression. The expression of cpxP is regulated by CpxR and has
been used as a reporter for the activation state of the cpx system [26,37]. We introduced a
cpxP-lacZ chromosomal reporter into ΔvexR and ΔvexRΔcpxRmutants. We then compared
cpxP-lacZ expression on LB-X-gal agar plates. In these assays we also included WT, ΔvexB,
ΔvexBDFHKM and ΔcpxRmutants as controls. The results showed that WT produced white
colonies on LB agar (S2 Fig.). This indicated that the Cpx system was inactive under standard
growth conditions as previously reported [37]. Growth of the same strain in the presence of
CuCl2, which is an inducer of the Cpx system, resulted in the formation of dark blue colonies.
This confirmed that the Cpx reporter system was functioning as expected. In contrast to WT,
the ΔvexRmutant produced light blue colonies on LB agar that were similar in appearance to
the ΔvexBmutant. This indicated that deletion of vexR, like deletion of vexB, resulted in activa-
tion of the Cpx system.
Since deletion of vexR activated the Cpx system, we tested whether the Cpx system affected
vexRAB expression in the ΔvexR background. If this was true we predicted that deletion of
cpxR in the ΔvexR background would result in decreased vexRAB expression and increased sen-
sitivity to VexAB efflux substrates. We first determined the effect of individual and combined
deletions of vexR and cpxR on erythromycin resistance. The results showed that the erythromy-
cin MIC for the ΔvexRΔcpxRmutant was not different from the ΔvexRmutant (S2 Table) sug-
gesting that the Cpx system is not contributing to enhance resistance to VexAB substrates in
the vexRmutant. Consistent with this result, deletion of cpxR in a ΔvexRmutant did not affect
vexRAB expression (S3 Fig.). Taken together these results confirmed that vexR deletion activat-
ed the Cpx system, but that the Cpx system did not affect the basal expression of vexRAB in the
absence of vexR. One potential explanation for this observation is that CpxR-dependent en-
hancement of vexRAB expression may require vexR.
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Overexpression of vexR enhances resistance to deoxycholate
We hypothesized that if vexR was required for vexRAB upregulation and antimicrobial resis-
tance, then vexR overexpression should complement a ΔvexRmutant for growth in the pres-
ence of deoxycholate and erythromycin. We tested this hypothesis by determining the
deoxycholate and erythromycin MIC for WT, ΔvexR and ΔvexRΔvexD strains that expressed
vexR from the arabinose promoter in pBAD18. In these experiments the respective strains con-
taining pBAD18 or pBAD18::vexR were grown on antimicrobial gradient agar plates that con-
tained a range of different arabinose concentrations. However, we were unable to identify an
arabinose concentration which resulted in complementation of the tested mutants for deoxy-
cholate or erythromycin resistance (data not shown). We considered that this result could have
been an artifact of the pBAD18 expression system, and therefore we cloned vexR into the low
copy number IPTG-inducible pMMB66EH expression vector and repeated the complementa-
tion experiments and obtained identical results.
The reason that we were unable to complement the vexRmutant is not clear. The inability
to complement the vexR deletion likely did not result from the introduction of a secondary mu-
tation during the construction of the vexRmutant since DNA sequencing confirmed the integ-
rity of the vexR deletion construct (i.e. pWM91::ΔvexR) and the vexRAB locus in the vexR
deletion strain. Further, the ΔvexR and ΔvexRΔvexDmutants were independently created from
different parental strains, making it unlikely that the complementation defect was due to an
unlinked spontaneous mutation. The lack of complementation was also not due to mutations
introduced into the complementing plasmids as we confirmed the DNA sequence of the com-
plementing plasmids. This latter conclusion is further supported by the observation that the
presence of pBAD18::vexR activated vexRAB-lacZ expression in E. coli (Fig. 3B).
Since the vexR deletion mutant could not be complemented by ectopic vexR expression, we
sought another method to confirm that VexR contributed to antimicrobial resistance. We hy-
pothesized that if vexR was indeed an activator of the vexRAB operon, then episomal expres-
sion of vexR in WT should result in enhanced growth in the presence of sub-lethal
concentrations of VexAB substrates. To test this hypothesis we generated growth curves for
WT(pBAD18::vexR) and WT(pBAD18) in LB broth containing a sub-lethal concentration of
deoxycholate. The results of this analysis showed that in the absence of deoxycholate, WT
(pBAD18::vexR) grew equally well during logarithmic phase of growth as WT(pBAD18)
through six hours (Fig. 4A). Thereafter WT(pBAD18) growth continued to increase whereas
the strain bearing pBAD18::vexR peaked and the cell density declined through 12 hours. This
indicated that over-expression of vexR is detrimental under standard laboratory growth condi-
tions. We speculated that this was a result of increased vexAB expression which has been sug-
gested to be growth inhibitory under non-selective conditions [27,39]. When the same strains
were cultured in LB broth containing deoxycholate, WT (pBAD18::vexR) exhibited a growth
advantage over the empty vector control regardless of the presence or absence of arabinose
(Fig. 4B). The addition of arabinose did not significantly affect the growth of WT(pBAD18::
vexR) relative to the same culture grown in the absence of arabinose (Fig. 4B). The complemen-
tation results were reminiscent of the findings observed for vexR activation of vexRAB in E. coli
(Fig. 3B) where vexR enhanced vexRAB-lux expression even in the absence of arabinose, and
further enhanced vexRAB-lux expression with the addition of arabinose. Taken together
these results provide additional support for the hypothesis that vexR contributes to vexRAB
activation.
The above results suggested that episomal vexR expression enhanced deoxycholate resis-
tance, but did not allow us to discriminate if the resistance phenotype was mediated by VexAB
or some other factor. If enhanced growth was due to VexR activation of VexAB production,
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then deletion of vexB should alleviate the vexR-dependent growth enhancement in the presence
of deoxycholate. We therefore repeated the above growth experiments in a vexB deletion strain.
The results showed that the growth of the ΔvexB(pBAD18) control strain was slightly attenuat-
ed relative to ΔvexB(pBAD18::vexR) in LB broth (Fig. 4C). This suggested that vexRmay im-
part a growth advantage in the vexBmutant during growth in LB broth. The growth of the
ΔvexB strain was significantly inhibited in the presence of deoxycholate (Fig. 4D). Unlike what
was observed in the WT background, vexR expression in the ΔvexBmutant did not significant-
ly affect cell growth (Fig. 4D). This suggested that the enhanced growth observed with vexR in
WT cells grown in the presence of deoxycholate may have resulted from vexR-dependent acti-
vation of the vexRAB operon (Fig. 4B). We also tested if pBAD18::vexR would provide a growth
advantage to a vexR deletion strain under the same growth conditions, but the results were con-
gruent with the gradient agar plate results and showed that pBAD18::vexR did not complement
the ΔvexRmutant (S4 Fig.). Taken together the collective results are consistent with the idea
that vexR overexpression enhanced V. cholerae growth in the presence of deoxycholate via the
VexAB RND efflux system.
Deletion of the RND efflux systems induces vexRAB expression
Recent studies in E. coli suggested that the RND systems may have evolved to remove poten-
tially toxic metabolites from the cell cytoplasm [40–42]. If this was true, we hypothesized that
Fig 4. VexR contributes to V. cholerae survival under inhibitory antimicrobial conditions. V. cholerae
N16961WT (A & B) and ΔvexB (C & D) containing pJB703(pBAD18::vexR) or pBAD18 were grown in
triplicate wells of microtiter plates containing LB broth (A & C) or LB broth plus 0.015% deoxycholate (B & D).
Expression of vexR was induced by adding 0.1% arabinose to the growth media as indicated. Cell growth was
monitored as the change in the optical density at 600 nm and plotted versus time as the mean ±SEM. The
results are representative of three independent experiments.
doi:10.1371/journal.pone.0117890.g004
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vexRAB expression would be upregulated in RND negative cells due to the accumulation of
metabolites that were substrates of the RND efflux systems. Consistent with this hypothesis
vexRAB has been reported to be upregulated in RND negative strain JB485 [26]. To further ex-
pand upon this and to determine whether vexR contributed to this phenotype we introduced
the vexRAB-lacZ reporter into WT, RND deficient strain JB485, and JB485ΔvexR. The resulting
strains were then cultured under AKI conditions in AKI broth for 5 h when vexRAB expression
was assessed (Fig. 5). AKI growth conditions were selected for these studies because previous
work had indicated a linkage between RND efflux and virulence gene expression [5]. The re-
sults showed a ~4.5-fold increase in vexRAB expression in JB485 confirming previous results
[26]. Deletion of vexR in JB485 reduced vexRAB expression to near background levels which
suggested that the increase in vexRAB expression in JB485 was dependent upon vexR (Fig. 5).
We next tested whether increased vexRAB expression in JB485 was due to loss of vexB or a
result of the deletion of all six RND efflux systems. We first quantified vexRAB expression in a
ΔvexBmutant. The results showed that vexRAB expression increased in the vexBmutant (~3-
fold), but to a level that was less than observed in JB485 (Fig. 5). This suggested that at least
one of the other RND systems can partially compensate for the loss of vexB. The expression of
vexRAB in a ΔvexDFHKM (vexB+) was not significantly different fromWT. This latter finding
was consistent with previous work showing that vexB, due to its broad substrate specificity, was
able to complement for the loss of the other five RND efflux systems [5,24]. Taken together
these results indicated that vexRAB expression was responsive to the RND efflux status of the
cell and that deletion of vexB resulted in vexRAB expression being elevated. The higher level of
vexRAB expression in JB485 relative to the vexBmutant suggested that one or more of the
other RND efflux systems were able to efflux the inducing factor(s). Based on these results we
inferred that V. cholerae compensates for reductions in RND efflux activity by upregulating
vexRAB expression. Exactly how V. cholerae senses efflux activity was unclear, but we speculat-
ed this resulted from the intracellular accumulation of natural substrates of the RND efflux sys-
tems in the absence of RND efflux activity.
Fig 5. Expression of vexRAB is induced in V. choleraeRND effluxmutants. The indicated N16961 strains
containing pXB233 (vexRAB-lacZ) were grown for 5 h under AKI conditions when vexRAB expression was
quantified as described in themethods. Strain JB485 is RND negative and lacks all six RND efflux pump
proteins. Error bars indicate ± SD of three independent experiments. One-way ANOVA with Dunnet’s post-hoc
test was used to determine significant differences relative toWT. * = P<0.05; ** = P<0.01; ***P =<0.0001.
doi:10.1371/journal.pone.0117890.g005
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The expression of vexRAB is altered in metabolic mutants
We tested whether V. cholerae upregulated vexRAB expression in response to the accumulation
of metabolic byproducts. Our approach for these experiments was based on the assumption
that the mutation of metabolic genes would disrupt biosynthetic pathways and result in the in-
tracellular accumulation of chemical intermediates of the targeted biochemical pathway which
would then activate vexRAB expression. To conduct these studies we obtained a number of
metabolic mutants from a defined transposon mutant library that was constructed in V. cho-
lerae El Tor strain C6706 [33]. We selected mutants that targeted a number of different meta-
bolic pathways including some that have been shown to affect E. coli acrAB expression [42].
This included mutants that affected purine metabolism, cysteine metabolism, sulfur metabo-
lism, vibriobactin biosynthesis, glycolysis, gluconeogenesis, pyruvate metabolism, amino acid
metabolism, and the citric acid cycle (S1 Table).
The metabolic mutants were transformed with pDT1777 (vexRAB-lux) and cultured in AKI
broth for five hours when vexRAB expression was quantified. While we were most interested in
the mutants that activated vexRAB expression, we noted several mutations reduced vexRAB ex-
pression. Based on the idea that vexRAB expression is modulated by metabolite accumulation,
one explanation for reduced vexRAB expression is the loss of down-stream activators. Howev-
er, we cannot exclude that the observed reduction of vexRAB expression was an artifact result-
ing from cellular byproducts inhibiting the luciferase reporter [43]. Three mutants were
identified (VC1172, VC1579, and VCA1046) that resulted in a>2-fold increase in vexRAB ex-
pression (S1 Table). VC1172 encodes TrpD which functions in tryptophan biosynthesis;
VC1579 encodes AlmE which is a lipid A modification enzyme [44]; and VCA1046 encodes
mannitol-1-phosphate 5-dehydrogenase and is involved in mannitol metabolism. These results
confirmed that vexRAB expression was upregulated in response to interruption of at least three
metabolic pathways. To further investigate this phenomenon we focused on tryptophan bio-
synthesis due to the availability of mutants and two chemical intermediates in the tryptophan
biosynthetic pathway.
Disruption of the tryptophan biosynthetic pathway affects vexRAB
expression
Mutation of trpD (VC1172) resulted in the strongest induction of vexRAB expression suggest-
ing that tryptophan biosynthesis intermediates may function as inducers of the vexRAB oper-
on. To investigate this we examined vexRAB expression in six different tryptophan
biosynthetic transposon mutants (Fig. 6A). The results showed that vexRAB expression in-
creased 3-fold in the trpBmutant, and ~2-fold in the trpA and trpDmutants (Fig. 6B). Muta-
tion of trpB (VC1170) is predicted to result in indole accumulation while mutation of trpA
(VC1169) and trpD (VC1172) would result in indole-3-glycerol phosphate and anthranilate ac-
cumulation, respectively. This suggests that indole, indole-3-glycerol phosphate and anthrani-
late could contribute to vexRAB induction.
If intermediates of tryptophan biosynthesis were vexRAB inducers, we hypothesized that
adding these compounds to the growth media would activate vexRAB expression. As anthrani-
late and indole were available from commercial sources, we tested if the addition of these com-
pounds affected vexRAB-lacZ expression in WT. The results showed that indole at 1.5 mM
increased vexRAB expression by ~1.5 fold (Fig. 6C). This finding, combined with the observa-
tion that vexRAB was induced in the trpBmutant (Fig. 6B), suggested that indole may contrib-
ute to vexRAB activation. The addition of anthranilate or tryptophan did not have a significant
effect on vexRAB expression (Fig. 6C). There are at least two explanations for this result. First,
it is possible that mutation of trpDmay have pleiotropic effects on other metabolic pathways
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which could be responsible for the effects on vexRAB expression. Second, it is also possible that
V. cholerae lacks an anthranilate transport system which would limit the effects of exogenous
anthranilate.
Indole is a substrate of the VexAB RND efflux system
Indole is an intermediate in the biosynthesis of tryptophan and is also produced by V. cholerae
as a byproduct of tryptophan degradation. Indole has also been shown to function as a signal-
ing molecule in biofilm formation [45,46]. At high concentrations indole is toxic, which sug-
gested that it may be a potential substrate of the V. cholerae RND efflux systems. We therefore
tested if the RND efflux systems contributed to indole resistance by comparing the growth of
WT and the RND deficient strain JB485 (ΔvexBDFHKM) on indole gradient agar plates. The
results showed that the WTMIC was 2.1 mM while the JB485 MIC was 1.6 mM (Table 3). This
suggested that the V. cholerae RND efflux systems contributed to indole resistance. In an effort
to determine which RND efflux systems contributed to indole resistance we examined mutants
lacking each of the six RND efflux systems pumps (i.e. vexB, vexD, vexF, vexH, vexK, vexM).
Only the vexBmutant had a small but significant decrease in the indole MIC (1.8 mM), which
was higher than the MIC exhibited by JB485 (Table 3). Although small, the change in the vexB
MIC was consistent with the idea that indole is a substrate of the VexAB RND efflux system.
Fig 6. Indole activates vexRAB expression. (A) Schematic of the V. cholerae tryptophan biosynthetic
pathway. (B) The indicated C6706 strains bearing pDT1777 (vexRAB-lux) were grown in 96-well plates under
AKI conditions for 5 h when luminescence (RLU) and OD600 were measured. Data are the mean +/- SEM of
three independent assays. Two-way Anova with Dunnet’s post-hoc test compared to WT was used to
determine significance. * = P<0.01; ** = P<0.0001. (C) V. choleraeN16961 containing pXB233 (vexRAB-
lacZ) was grown with or without indole, L-tryptophan, or anthranilic acid at the indicated concentrations under
AKI conditions for 5 h before vexRAB expression was determined as described in the methods. Bars indicate
the mean +/- SD of three independent experiments. One-way ANOVA with Dunnet’s post-hoc test was used
to determine significant changes relative to growth in media alone. * = P<0.001.
doi:10.1371/journal.pone.0117890.g006
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The discrepancy between the vexB and JB485 MICs suggest that at least one of the other RND
efflux systems function in indole resistance. All together this data indicates that indole may be
a substrate of the RND efflux systems and that indole may serve as an inducer of the
vexRAB operon.
Discussion
The VexAB RND efflux system was the only V. cholerae RND system that was associated with
a linked TetR family regulator (Fig. 1). In contrast to what is observed with most RND loci,
VexR was encoded as the first gene in the vexRAB operon. VexR contributed to vexRAB expres-
sion as evidenced by the finding that vexR deletion decreased vexRAB expression (Fig. 3A) and
resulted in increased susceptibility to the VexAB substrate erythromycin (Table 2). These re-
sults indicated that vexR contributed to the positive regulation of the vexRAB operon. This con-
clusion was supported by subsequent experiments showing that VexR directly bound the
vexRAB promoter (Fig. 3C), that VexR was able to increase vexRAB expression in E. coli
(Fig. 3B), and that vexR overexpression in V. cholerae resulted in a vexB-dependent growth ad-
vantage in the presence of sub-lethal concentrations of deoxycholate (Fig. 4).
The finding that VexR was required for vexRAB expression was unexpected. The vast majority
of TetR-family regulators behave as transcriptional repressors [30]. Thus our findings highlight
differences in the regulation of vexRAB relative to its orthologous Enterobacteriaceae system (i.e.
acrR-acrAB). In E. coli acrR functioned as a negative regulator of acrAB while global regulatory
systems such as the Mar operon functioned to positively regulate acrAB expression in response
to antimicrobial exposure (Fig. 1) [28,29]. Although V. cholerae lacks the Mar operon, VexR
could function in a similar role as the Mar operon by contributing to vexRAB expression in re-
sponse to antimicrobial exposure. It is worth noting that the vexRAB and vexGH RND efflux sys-
tems and the Cpx system are reciprocally regulated in V. cholerae [26]. Recent studies showed
that mutation of vexB or vexH resulted in activation of the Cpx system while activation of the
Cpx system resulted in upregulation of vexRAB and vexGH. Herein our results show that deletion
of vexR resulted in activation of the Cpx system (S2 Fig.), but that Cpx activation did not affect
vexRAB expression (S3 Fig.) or VexAB mediated antimicrobial resistance (S2 Table). This result
may suggest that the Cpx-dependent upregulation of the vexRAB operon is dependent on vexR.
Table 3. Minimum inhibitory concentration of indole for RND mutants.
Strain Genotype Indole MIC (s.d)1
JB58 WT 2.1 (0.1)
XBV218 ΔvexR 2.0 (0.2)
JB495 ΔvexB 1.8 (0.2)2
JB692 ΔvexD 2.0 (0.2)
JB432 ΔvexF 2.0 (0.1)
JB116 ΔvexH 2.1 (0.1)
JB528 ΔvexK 2.1 (0.1)
JB114 ΔvexM 2.0 (0.1)
JB485 ΔvexBDFHKM 1.6 (0.1)3
(1)Minimum Inhibitory Concentration (MIC) of Indole (mM) for the indicated N16961 strains. One-way
ANOVA with Dunnet’s post-hoc test was used to determine statistical difference relative to WT.
(2) P< 0.05 relative to WT;
(3) P<0.001 relative to WT.
doi:10.1371/journal.pone.0117890.t003
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The fact that the Cpx system does not respond to antimicrobial substrates of the V. cholerae
RND efflux systems further indicates that vexRAB expression is under the influence regulatory
systems that respond to distinct stimuli. This could explain the inability to transcomplement the
vexR deletion strain. It is possible that VexR-dependent regulation of the vexRAB operon is de-
pendent on VexR interaction with other regulatory elements. Alternatively, cis-acting sequencing
within the vexR open reading frame could be required for vexRAB upregulation.
The expression of vexRAB was highly elevated upon loss of RND-mediated efflux (Fig. 5).
This upregulation was abolished when vexR was deleted (Fig. 5), indicating that vexR was re-
quired for vexRAB expression in the RND efflux mutants. This suggested the possibility that me-
tabolites accumulated within the cell and induced vexRAB expression in the absence of RND-
mediated efflux. This idea is consistent with recent reports in E. coli which have linked efflux to
cell metabolism [40–42,47]. The finding that vexRAB expression was upregulated in three of the
36 tested metabolic mutants provided evidence to support this hypothesis (S1 Table). Altogether,
this suggests the VexAB RND efflux system plays a role in removing excess metabolites from the
cell. While vexRAB was induced in three of the metabolic mutants, it is also possible that other ef-
flux systems may function in a similar or redundant role to remove other metabolites from the
cell. Precedence for this was found in E. coli where the acrEF, yfiK and aaeAB efflux systems con-
tributed to indole, cysteine-cystine, and p-hydroxybenzoate export, respectively [48–50]. The fact
that vexRAB expression in the ΔvexBwas lower than what was observed in RND negative strain
JB485 supports the conclusion that other V. cholerae RND efflux systems also participate in the
removal of excess metabolites from within the cell (Fig. 5).
The mutations that activated vexRAB expression disrupted three different metabolic path-
ways. This suggested that vexRAB expression is modulated in response to multiple different
metabolites (S1 Table and Fig. 6B). The mutation of trpB resulted in the greatest increase in
vexRAB expression. Since TrpB catalyzes the conversion of indole to tryptophan (Fig. 6A), this
suggested that indole likely contributed to vexRAB induction in the trpBmutant (Fig. 6). Acti-
vation of vexRAB expression by exogenous indole supported this conclusion (Fig. 6C). In addi-
tion, both JB485 and the ΔvexBmutant exhibited increased susceptibility to indole. This
suggested that indole was a substrate for VexAB and likely additional RND efflux systems
(Table 3). Based on the fact that indole both contributed to induction, and likely functioned as
a substrate of vexRAB, we propose that the VexAB efflux system functions to remove excess in-
dole from within the cell before it reaches concentrations that are detrimental to cell growth.
Given the broad substrate specificity of the VexAB system, combined with the observation that
vexRAB was induced in two other metabolic mutants; we suggest that the function of VexAB in
metabolic relief may extend beyond indole.
In conclusion, we have shown that vexR contributed to the positive regulation of vexRAB.
VexR appears to be necessary for activation of the vexRAB operon in response to efflux sub-
strates of the VexAB RND efflux system. The finding that vexR was necessary for positive regu-
lation was unusual. To the best of our knowledge only ten TetR family regulators from the
more than 20,000 distinct TetR family proteins have been characterized as activators [29,51–
61]. However, it is possible that TetR activators may be more common than currently thought
as only a fraction of the annotated TetR proteins have been characterized. We have also estab-
lished a novel role for VexAB in responding to the metabolic state and efflux status of the cell.
We suggest that that vexRAB expression is modulated in response to metabolic products and
that VexAB relieves stress by preventing the accumulation of metabolic byproducts to toxic
levels. Our results were similar to what has been observed in E. coli where metabolic mutants
and metabolic products were found to activate the acrAB RND system [40–42,47]. Therefore,
the ability of the RND efflux systems to alleviate stress due to excess metabolites appears to be
an evolutionarily conserved mechanism.
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Supporting Information
S1 Fig. Effect of VexR on the expression of Vibrio cholerae RND efflux systems. Overnight
cultures of Vibrio cholerae strain JB58 (N16961 ΔlacZ SmR) or the isogenic ΔvexRmutant bear-
ing the transcriptional fusion reporters for the indicated RND efflux system were diluted 1:100
into LB broth and grown with shaking for 3.5 h at 37°C when deoxycholate (DOC) was added
to 0.02%. The culture was incubated with shaking at 37°C for an additional 30 min when ali-
quots were collected in triplicate and β-galactosidase activity was quantified as described in the
methods. (A.) vexCD; (B.) vexEF; (C.) vexGH; (D.) vexIJK; (E.) vexLM. The reported results are
in Miller Units (MU) and are the mean ± SD of three independent experiments.
(PDF)
S2 Fig. Deletion of vexR results in upregulation of the Vibrio cholerae Cpx system. The indi-
cated strains containing a chromosomal cpxP-lacZ transcriptional reporter were cultured over-
night in LB broth before being diluted 1:100 into fresh LB broth. The cultures were incubated
an additional hour and diluted 1,000-fold into PBS. Aliquots of the diluted cultures were then
inoculated onto the surface of LB agar plates containing X-gal (160 μg/mL) plus and minus
500 μMCuCl2 (to induce expression of the Cpx system). The plates were then incubated over-
night at 37°C before being photographed.
(PDF)
S3 Fig. CpxR does not affect vexRAB expression in a vexRmutant. The indicated V. cholerae
N16961 strains containing a vexRAB-lacZ transcriptional reporter were cultured to middle log-
arithmic phase in LB broth when vexRAB-lacZ expression was quantified by a β-galactosidase
assay as described in the methods. The results are the average ±SD of five independent experi-
ments.
(PDF)
S4 Fig. Episomal vexR expression does not provide a growth advantage to a vexR deletion
mutant. V. choleraeN16961 ΔvexR containing pJB703 (pBAD18::vexR) or pBAD18 were grown
in triplicate wells of microtiter plates containing (A) LB broth or (B) LB broth plus 0.015% deoxy-
cholate. Arabinose (0.1%) was added to the media as indicated to induce expression of vexR from
the arabinose regulated promoter in pBAD18. Cell growth was then monitored as the change in
the optical density at 600 nm and plotted versus time as the mean ±SEM.
(PDF)
S1 Table. Expression of vexRAB in C6706 metabolic mutants.
(PDF)
S2 Table. Minimum inhibitory concentration of erythromycin for Vibrio choleraemutants.
(PDF)
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